Keyphrases
Alzheimer's Disease
62%
Sporadic Alzheimer's Disease
28%
Autosomal Dominant Alzheimer's Disease
26%
Cerebrospinal Fluid
24%
Positron Emission Tomography
15%
Cognitively Normal
14%
Mutation Carriers
12%
Pittsburgh Compound B
11%
Alzheimer's Disease Pathology
11%
Alzheimer's Disease Biomarkers
11%
Symptom Onset
10%
Dominantly Inherited Alzheimer Network
10%
Magnetic Resonance Imaging
10%
Dominantly Inherited Alzheimer's Disease
9%
Amyloid Imaging
9%
Cognitive Impairment
9%
Older Adults
9%
Non-carriers
9%
Cerebrospinal Fluid Biomarkers
9%
Cognitive Decline
8%
White Matter
7%
Amyloid Positron Emission Tomography
7%
Neurodegeneration
7%
Multiple Sclerosis
7%
Imaging Biomarkers
7%
Apolipoprotein E
7%
Amyloid PET
7%
Standardized Uptake Value
6%
Phosphorylated tau
6%
Amyloid Burden
6%
Hippocampal Volume
6%
White Matter Hyperintensities
6%
Aging
6%
Tau Positron Emission Tomography
6%
Tau Pathology
6%
APOE4
5%
Neuroinflammation
5%
Alzheimer's Dementia
5%
Amyloid Deposition
5%
Dementia
5%
Tau PET
5%
Amyloid beta
5%
Resting-state Functional Connectivity (rs-FC)
5%
Longitudinal Change
5%
Clinical Dementia Rating
5%
Total tau
5%
Atrophy
5%
Autosomal Dominant
5%
Presenilin
5%
Sphingosine-1-phosphate Receptor (S1PR)
5%
Neuroscience
Alzheimer's Disease
100%
Amyloid Protein
49%
Positron Emission Tomography
21%
Positron Emission Tomography
18%
Magnetic Resonance Imaging
13%
Fluorine-18
10%
Magnetic Resonance Imaging
10%
Neurodegeneration
9%
Cognitive Disorders
8%
Multiple Sclerosis
6%
Blood Plasma
6%
Apolipoprotein E
6%
Amyloidosis
5%
In Vivo
5%
Functional Connectivity
5%
Beta Amyloid
5%
Diffusion Tensor Imaging
5%
Resting-State Functional Connectivity
5%
Medicine and Dentistry
Alzheimer's Disease
57%
Amyloid Protein
32%
Tau
22%
Positron Emission Tomography
18%
Biological Marker
17%
Cerebrospinal Fluid
17%
Autosomal Dominant Inheritance
14%
Polyethylene Terephthalate
11%
Magnetic Resonance Imaging
11%
Pittsburgh Compound B
8%
Radioactive Tracer
6%